News Sentiment

VISTN sentiment intelligence

Vistin Pharma ASA news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 50 Balanced news tone 6 relevant articles
Exchange OSL Norway
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 20.40 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

68/100 classification confidence.

Company focus 6

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+0.0% over one week, -0.5% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Vistin Pharma ASA (OB: VISTN) Stock Ex-Dividend Deadline Approaches as Income Investors Weigh Payout Sustainability

Market Reaction

Balanced read

44/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 68/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive -0.5% over four weeks
Fair value -2.5% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 6
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 6
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
GlobeNewswire 3
foreignpolicyjournal.com 1
TradingView 1
BioPharma Dive 1

Event Lens

What the news is about

Classified themes
Market update 3
Earnings 3

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-6 of 6